DMCC re-appoints MD & CEO Bimal Goculdas for 3 years, Q3 profit up
DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 4.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DMCC board approved Q3 FY26 results: net sales rose about 28 percent YoY to Rs 15,083 lakhs, but net profit fell to Rs 616 lakhs from Rs 788 lakhs. 9M FY26 net profit was Rs 1,967 lakhs (Rs 7.89 EPS). Re-appointed Bimal Goculdas as MD and CEO for 3 years from April 1, 2026, pending shareholder approval. Also approved a pay hike for Executive Director Kuldeep Tiwari and amendments to MOA and AOA, both needing postal ballot approval.
Leadership continuity with Goculdas re-appointed. Revenue grew strongly but margins dipped. MOA changes give the company more operational flexibility.